Chunguang Jiuhui

Hunan Chunguang Jiuhui Modern Chinese Medicine Co., Ltd. is a modern pharmaceutical enterprise integrating production and distribution, mainly engaged in traditional Chinese medicine decoction pieces, ultra-micro traditional Chinese medicine decoction pieces (ultra-micro traditional Chinese medicine formula granules), finished medicine preparations, traditional Chinese medicine extracts, health food, and cultivation of Chinese medicinal materials. It is controlled by Hunan Xingxiang Investment Holding Group Co., Ltd., a provincial state-owned capital operation company. The company currently has two controlled subsidiaries: Hunan Pharmaceutical Co., Ltd. and Hunan Ranruntang Traditional Chinese Medicine Co., Ltd. The company's headquarters is located in Changsha High-tech Zone, and its production bases are respectively located in Liuyang Economic and Technological Development Zone (Changsha National Biological Industry Base) and Ningxiang Economic Development Zone, with a total area of nearly 180 mu. The company's self-owned and cooperative Chinese medicinal material cultivation bases cover an area of nearly 10,000 mu.
Relying on the jointly established *Ultra-micro Engineering Research Center with Hunan University of Chinese Medicine and Hunan Academy of Chinese Medicine, the company is committed to promoting the development of the traditional Chinese medicine industry. It is the undertaking unit of the National Development and Reform Commission's "High-tech Industrialization Demonstration Project for Ultra-micro Traditional Chinese Medicine Decoction Pieces" and "High-tech Industrialization Demonstration Project for Standard Traditional Chinese Medicine Extracts," the undertaking unit of the "National Standardization Construction Project for Lily and Evodia Traditional Chinese Medicine Decoction Pieces," and the main undertaking unit for the formulation of the Ministry of Science and Technology's "Industry Standard for Ultra-micro Traditional Chinese Medicine Decoction Pieces" and "Industry Standard for Traditional Chinese Medicine Extracts." The company owns multiple patents, including "Processing Technology for Single-herb Ultra-micro Traditional Chinese Medicine Granules" and "Ginkgo Tea Preparation and Its Production Process."
The company's core product—ultra-micro traditional Chinese medicine decoction pieces (ultra-micro traditional Chinese medicine formula granules)—was developed over many years by 60 expert professors from Hunan University of Chinese Medicine and Hunan Academy of Chinese Medicine. It is a production process combining traditional Chinese medicine processing technology, modern traditional Chinese medicine extraction technology, and ultra-micro cell wall breaking technology. It is an innovation and development of traditional Chinese medicine decoction pieces, breaking China's five-thousand-year use of the "medicine pot" and opening a new era for the traditional Chinese medicine industry. In recent years, it has won the First Prize of Hunan Provincial Science and Technology Progress Award, the Second Prize of National Science and Technology Progress Award, and the China Patent Excellence Award. The company has been rated as a "High-tech Enterprise" in Hunan Province and a key listed reserve enterprise in Hunan Province. It has been listed in the Hunan Province Strategic Emerging Industry Top 100 Enterprises Directory, is an executive director unit of the Hunan Province Pharmaceutical Industry Association, an executive director unit of the Hunan Province Traditional Chinese Medicine Industry Technology Innovation Alliance, and the chairman unit of the Changsha Traditional Chinese Medicine Industry Technology Innovation Strategic Alliance.
The enterprise has completely independent intellectual property rights and strong research and development capabilities. It is the * domestic manufacturer in the traditional Chinese medicine field to develop and produce "ultra-micro traditional Chinese medicine," and also the * domestic rights holder in the traditional Chinese medicine decoction pieces industry permitted to use the "ultra-micro" trademark. In the field of decoction-free traditional Chinese medicine, the company's products are original, leading similar products in terms of efficacy and production process. The market scale has increased year by year, products are in short supply, and reputation is high.
The company adheres to a market-oriented approach, aims to meet customer needs and exceed customer expectations, further strengthens core competitiveness, and continuously enhances its visibility and brand influence in the industry. The company will uphold the enterprise spirit of "dedication, professionalism, loyalty, and diligence," aim to inherit the essence of traditional Chinese medicine, take improving human quality of life as its mission, and strive to build a nationally renowned * traditional Chinese medicine enterprise. We now sincerely invite talented individuals to join us and seek a better future together with our company.